Coastlands Capital LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Coastlands Capital LP
CRD #335329
SEC #801-132421
CIK #0002068530
AUM 785.0 M (2026-04-30)
Employees 5 (60% Investors, 0% Brokers)
Fees
Minimum
Phone415-249-1282
Address601 California Street
San Francisco, CA 94108
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
80064048032016002010201520212027
Fees and Compensation — Form ADV Part 2A (3/27/2026) [Brochure]
Item 5.        Fees and Compensation

A. Fee Schedule

Coastlands delivers this brochure to prospective investors and clients that are qualified purchasers as
defined in Section 2(a)(51)(A) of the Investment Company Act of 1940, as amended. Therefore,
information on how Coastlands is compensated for its advisory services and its fee schedule with
respect to its clients and Funds are not included here.

B. Payment of Fees

Coastlands deducts management fees and performance fees or allocations directly from client
accounts.

Relationships with a Fund are terminable on expiration of the Fund’s term, dissolution of the Fund or
on Coastlands’ termination as investment adviser of the Fund. Relationships with other clients are
terminable on the termination of the investment adviser agreement. Each investor may
withdraw capital from a Fund only on specified prior written notice and subject to significant

withdrawal limitations as specified in the applicable Fund’s governing documents. Investors should
refer to the Funds’ offering documents for specific information.

Except as may be otherwise negotiated in particular cases, the holder of an individually managed
account may terminate the account by giving 60 days prior written notice.

In all cases, expenses, the pro rata portion of the management fee and the performance fee or
allocation through the date of the investor’s withdrawal or termination of the client account are
charged to the investor or client. All prepaid but unearned advisory fees are refunded on termination
of a client’s account. An investor who withdraws from a Fund on a date other than the last day of a
month, however, does not receive a refund of the management fee previously paid.

Coastlands believes that its fees are competitive with those charged by other investment advisers for
comparable services. Comparable services may be available, however, from other sources for
lower fees.

C. Third-Party Fees

Each client is responsible for its own costs and expenses related to its organization and ongoing
operations, including, without limitation, trading costs and expenses (such as brokerage
commissions, order execution costs, expenses related to short sales, and clearing and settlement
charges), third-party research and software costs, ongoing legal, accounting and bookkeeping fees
and expenses, and the fees and expenses charged by any Fund administrator for its accounting,
bookkeeping and other services. Investors should refer to the Funds’ offering documents for specific
information. In addition, certain of Coastlands’ own costs and expenses may be paid by securities
brokerage firms that execute clients’ securities trades, as discussed in Item 12 below.

Accounts that invest in mutual funds also pay, indirectly, investment advisory fees to the managers
of those funds.
Account Minimums and Types of Clients — Form ADV Part 2A (3/27/2026) [Brochure]
Item 7.          Types of Clients

Coastlands provides investment advice to the Funds and may provide advice to other clients in the
future. Investors in the Funds are required to invest a minimum of $5 million, but Coastlands may
waive this minimum. Coastlands’ clients are expected to include other investment firms, sovereign
wealth funds, endowments, pension plans and other institutional investors.
Type Form D Funds Date Sold AUM
HF Coastlands Capital Partners LP [2025-03-14] 606.0 M 785.0 M
Filed 2025-11-18 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 1 785.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 1 785.0
By Discretionary
Discretionary 1 785.0
Non-Discretionary 0 0.0
Total 1 785.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 785.0
Total 1 785.0
Form D Directors Role # Filings # Firms 2011 - 2026
Mark Shamia Executive Officer 14 4
Matthew Perry Executive Officer 8 3
Coastlands Capital GP LLC Executive Officer 1 1
EDGAR Form CIK 2011 - 2026
3 [0002068530]
4 [0002068530]
SC 13D [0002068530]
SC 13G [0002068530]
Form 13D/13G Filer Form 13D/13G Subject Filed
Coastlands Capital LP Adial Pharmaceuticals Inc [2026-06-24]
Coastlands Capital LP Eloxx Pharmaceuticals Inc [2026-06-17]
Coastlands Capital LP Eloxx Pharmaceuticals Inc [2026-05-01]
Coastlands Capital LP Pasithea Therapeutics Corp [2026-02-27]
Coastlands Capital LP Minerva Neurosciences Inc [2026-02-20]
Coastlands Capital LP Xilio Therapeutics Inc [2025-12-11]
Coastlands Capital LP Eledon Pharmaceuticals Inc [2025-11-24]
Coastlands Capital LP Neuphoria Therapeutics Inc [2025-11-05]
Coastlands Capital LP X4 Pharmaceuticals Inc [2025-10-03]
Coastlands Capital LP X4 Pharmaceuticals Inc [2025-08-18]
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund
LEI254900TRHLE4GPWU4946
Form 3/4/5 Subject 2011 - 2026
Coastlands Capital LP
Adial Pharmaceuticals Inc
Pasithea Therapeutics Corp
Senesco Technologies Inc
Comparable Firms State AUM
Saturn V Capital Management LP
TX 793.2 M
KR Capital LP
NY 792.4 M
Land & Buildings Investment Management LLC
CT 790.1 M
Global IMC LLC
CA 790.0 M
Inceptionr LLC
786.1 M
Enhalus Capital LP
NY 785.5 M
Artia Global Partners LP
FL 778.9 M
M3F Inc
UT 778.2 M
Newgen Asset Management Limited
774.8 M
Habrok Capital Management LLP
774.3 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com